|RI4 -- Germany Stock|| |
EUR 0.19 0.014 6.86%
Dr. Suresh Venkatesan serves as Chief Executive Officer, Chief Technology Officer, Director of the Company. He was Chief Executive Officer, Director of the Company. Dr. Suresh Venkatesan was most recently Senior Vice President, Technology Development at GLOBALFOUNDRIES and was responsible for the companys Technology Research and Development. Dr. Venkatesan joined GLOBALFOUNDRIES in 2009, where he led the development and ramp of the 28nm node and was instrumental in the technology transfer and qualification of 14nm. In addition, he was responsible for the qualification and ramp up of multiple mainstream value added technology nodes. Dr. Venkatesan is an industry veteran with over 22 years of experience in semiconductor technology development. Prior to joining GLOBALFOUNDRIES, he held various leadership positions with Freescale Semiconductor in Austin, Texas
CEO Since 2017
Venkatesan holds over 25 US patents, and has coauthored over 50 technical papers. He holds a Bachelor of Technology degree in Electrical Engineering from the Indian Institute of Technology and MS and PhD degrees in Electrical Engineering from Purdue University.
The company has return on total asset (ROA)
of (24.01) %
which means that it has lost $24.01 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (40.66) %
meaning that it generated substantial loss on money invested by shareholders.
POET Technologies Inc. designs, manufactures, and sells semi-conductor products in the United States, Canada, and Singapore. The company was formerly known as Opel Technologies Inc. and changed its name to POET Technologies Inc. in June 2013. POET Technologies operates under Semiconductors classification in Germany and traded on Frankfurt Stock Exchange. It employs 68 people.POET Technologies (RI4) is traded on Frankfurt Stock Exchange in Germany. It is located in 120 Eglinton Avenue East and employs 68 people.
POET Technologies Leadership Team
|Suresh Venkatesan, CEO|
|Thomas Mika, CFO, MBA|
|Michel Lafrance, Executive|
|Mohandas Warrior, Director, MBA|
|Ajit Manocha, Chairman|
|Peter Charbonneau, Director, MBA|
|Kevin Barnes, CFO|
|Dan Desimone, CTO|
|Donald Listwin, Director|
|Peter Copetti, Director|
|David Lazovsky, Director|
|Todd DeBonis, Director|
|Stephane Gagnon, President|
|JeanLouis Malinge, Director, MBA|
|John ODonnell, Director|
|Chris Tsiofas, Director|
|Subhash Deshmukh, COO, Ph.D|
Stock Performance Indicators
Macroaxis portfolio users are evenly split in their perspective on investing in POET Technologies. What is your perspective on investing in POET Technologies? Are you bullish or bearish?